Related Experiment Video
Updated: Aug 16, 2025

An “All-laser” Endothelial Transplant
Published on: July 6, 2015
Update on Femtosecond Laser-Enabled Keratoplasty
1Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN; and.
Femtosecond lasers enhance corneal transplantation (FLEK) by improving precision and healing. Femtosecond laser-deep anterior lamellar keratoplasty (Femto-DALK) reduces rejection risk, offering better visual outcomes for patients.
Area of Science:
- Ophthalmology
- Surgical Technology
- Biomedical Engineering
Background:
- Corneal diseases necessitate transplantation for vision restoration.
- Conventional keratoplasty techniques face challenges in precision and healing.
- Femtosecond laser technology offers potential advancements in corneal surgery.
Purpose of the Study:
- To evaluate the benefits of femtosecond laser-enabled keratoplasty (FLEK) and Femtosecond laser-enabled deep anterior lamellar keratoplasty (Femto-DALK).
- To assess improvements in visual outcomes and graft rejection rates.
- To explore novel applications of femtosecond laser precision in lamellar keratoplasties.
Main Methods:
- Application of femtosecond lasers for customized trephination in donor and host matching.
- Comparison of FLEK and Femto-DALK with conventional penetrating keratoplasty.
- Analysis of clinical cohorts for visual outcomes and graft rejection.
Main Results:
- FLEK demonstrates meaningful improvements in visual outcomes and a lower risk of graft rejection.
- Femto-DALK eliminates the risk of endothelial rejection by combining femtosecond laser precision with deep anterior lamellar keratoplasty.
- Customized trephination enhances wound integrity and precision at the graft interface, promoting faster healing.
Conclusions:
- Femtosecond laser technology significantly advances corneal transplantation, offering improved precision, faster visual rehabilitation, and reduced rejection rates.
- Femto-DALK presents a promising alternative for patients, mitigating endothelial rejection risks.
- Further research, including prospective randomized-controlled trials, is needed to confirm long-term outcomes and optimize patient accessibility.
More Related Videos
05:46Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
08:48Low-cost Custom Fabrication and Mode-locked Operation of an All-normal-dispersion Femtosecond Fiber Laser for Multiphoton Microscopy
Published on: November 22, 2019